题名 | Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study. |
作者 | Kwo P1, Gitlin N2, Nahass R3, Bernstein D4, Etzkorn K5, Rojter S6, Schiff E7, Davis M8, Ruane P9, Younes Z10, Kalmeijer R11, Sinha R11, Peeters M12, Lenz O12, Fevery B12, De La Rosa G13, Scott J14, Witek J11. |
杂志 | Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467. [Epub ahead of print] |
年|卷|期 | Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467. [Epub ahead of print] |
页码 | Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467. [Epub ahead of print] |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/26799692 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |